February 26, 2025
1 min watch
Save
VIDEO: Data support use of aflibercept 8 mg in treatment of retinal vein occlusion
KOLOA, Hawaii — In this expert perspective from Hawaiian Eye 2025, W. Lloyd Clark, MD, discusses the use of aflibercept 8 mg in the treatment of retinal vein occlusion.
Clinical trial data support the use of higher-dose VEGF inhibition, he said.
“I’m very excited about these clinical trial results, and as we move forward into 2025, I’m hopeful that we’ll have this treatment option available to us to improve clinical outcomes with retinal vein occlusion,” Clark said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio interviews
Disclosures:
Clark reports being a consultant and investigator for Neurotech.
Read more about